Showing 1821-1830 of 2936 results for "".
MATV News: Revance RT002 Positive Results; RealSelf Trends Report; Jawline Aesthetics
https://modernaesthetics.com/series/matv-news/matv-news-revance-rt002-positive-results-realself-trends-report-jawline-aesthetics/33463/Revance Therapeutics RT002 delivered positive top-line results in alleviating moderate to severe glabellar lines, social media presence may matter more than experience in patient Google searches, and RealSelf reveals the latest annual trends in cosmetic treatments. Plus, the ASPS names Steven WilliaFinancial Planner: Year-End Tax Planning Tips for 2018
https://modernaesthetics.com/ma-issues-index/2018-nov-dec/year-end-tax-planning-tips-for-2018/34055/What to do now and a review of a new deduction for business owners.MATV News: Restylane Lyft with Cannula Approved, New AAFPRS President, Plastic Surgery Trends
https://modernaesthetics.com/series/matv-news/matv-news-restylane-lyft-with-cannula-approved-new-aafprs-president-plastic-surgery-trends/33253/The FDA has approved the use of Restylane Lyft with a small, blunt-tip cannula for cheek augmentation and midface contour deficiencies, Dr. Phillip R. Langsdon is the new President of The American Academy of Facial Plastic and Reconstructive Surgery, and a new study looks at how aging affects facialMATV News: Avoiding Serious Complications from Injectable Fillers
https://modernaesthetics.com/series/matv-news/matv-news-avoiding-serious-complications-from-injectable-fillers/33255/Soft-tissue fillers continue to rise in popularity among US consumers seeking aesthetic treatments. And although severe complications from dermal fillers are uncommon, they do unfortunately occur, and treating physicians must understand the risks and be prepared to treat complications. In this speciCutting Edge Marketing for Surgical Procedures
https://modernaesthetics.com/ma-issues-index/2018-sept-oct/cutting-edge-marketing-for-surgical-procedures/34073/How to promote tried-and-true surgical procedures in the era of little-to-no-downtime.Three Ways: Chatting About Chatbots: Are They a Necessity?
https://modernaesthetics.com/ma-issues-index/2018-sept-oct/chatting-about-chatbots-are-they-a-necessity/34076/Do chatbots make sense for your website?MATV News: Patient Satisfaction Factors; 2018 AES Update; Spotlyte Launch
https://modernaesthetics.com/series/matv-news/matv-news-patient-satisfaction-factors-2018-aes-update-spotlyte-launch/33260/New research examines what influences patient satisfaction most following plastic surgery, update from the 2018 Aesthetic Extender Symposium, Thermi launches Arvati, and Allergan debuts thespotlyte.com for consumer education on aesthetic medicine. Plus, what do the new guidelines for treatment teensMATV News: Brazilian Butt Lift Advisory; Patient Engagement Report; More
https://modernaesthetics.com/series/matv-news/matv-news-brazilian-butt-lift-advisory-patient-engagement-report-more/33261/Multi-Society Task Force for Safety in Gluteal Fat Grafting releases a practice advisory, the FDA cracks down on vaginal rejuvenation claims, Evolus resubmits BLA for DWP-450, and eRelevance shares results of new patient engagement report. Plus, is “SnapChat Dysmorphia” creating unrealistic expectatMake Your Practice Thrive By Improving Conversion Rates
https://modernaesthetics.com/ma-issues-index/2018-july-aug/make-your-practice-thrive-by-improving-conversion-rates/34091/Understanding your current and prospective patients is critical to driving conversions.MATV News: RealSelf Worth It Ratings; Cutera and Candela Launches; FDA Approves Qbrexza
https://modernaesthetics.com/series/matv-news/matv-news-realself-worth-it-ratings-cutera-and-candela-launches-fda-approves-qbrexza/33264/Demand for fat reduction and interest in vaginal rejuvenation at all-time high, RealSelf reports, Cutera and Candela both launch new devices, and there's a new FDA-approved treatment for hyperhidrosis. Plus, find out how the first #RealDealAesthetics Twitter Chat went, and share your thoughts on cho